Cutaneous graft-versus-host disease on Tc-99m leukocyte scintigraphy

Erik Mittra, I. Ross McDougall

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Leukocyte scintigraphy has previously been used to evaluate gastrointestinal graft-versus-host disease (GVHD). No reports have described their utility in cutaneous GVHD or the ability of leukocyte scintigraphy to evaluate treatment response at any site. This case shows significant radiolabeled leukocyte uptake in a man with extensive cutaneous GVHD, with subsequent near complete resolution after therapy. As such, leukocyte scintigraphy may provide an alternate way to assess the burden of GVHD and response to treatment.

Original languageEnglish (US)
Pages (from-to)894-895
Number of pages2
JournalClinical Nuclear Medicine
Volume34
Issue number12
DOIs
StatePublished - Dec 1 2009
Externally publishedYes

Fingerprint

Graft vs Host Disease
Radionuclide Imaging
Leukocytes
Skin
Therapeutics

Keywords

  • Cutaneous
  • Graft-versus-host disease
  • Tc-99m leukocyte scan
  • Treatment response
  • WBC

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Cutaneous graft-versus-host disease on Tc-99m leukocyte scintigraphy. / Mittra, Erik; McDougall, I. Ross.

In: Clinical Nuclear Medicine, Vol. 34, No. 12, 01.12.2009, p. 894-895.

Research output: Contribution to journalArticle

@article{4553215496ef4f24a99aba61ea9232ad,
title = "Cutaneous graft-versus-host disease on Tc-99m leukocyte scintigraphy",
abstract = "Leukocyte scintigraphy has previously been used to evaluate gastrointestinal graft-versus-host disease (GVHD). No reports have described their utility in cutaneous GVHD or the ability of leukocyte scintigraphy to evaluate treatment response at any site. This case shows significant radiolabeled leukocyte uptake in a man with extensive cutaneous GVHD, with subsequent near complete resolution after therapy. As such, leukocyte scintigraphy may provide an alternate way to assess the burden of GVHD and response to treatment.",
keywords = "Cutaneous, Graft-versus-host disease, Tc-99m leukocyte scan, Treatment response, WBC",
author = "Erik Mittra and McDougall, {I. Ross}",
year = "2009",
month = "12",
day = "1",
doi = "10.1097/RLU.0b013e3181bed148",
language = "English (US)",
volume = "34",
pages = "894--895",
journal = "Clinical Nuclear Medicine",
issn = "0363-9762",
publisher = "Lippincott Williams and Wilkins",
number = "12",

}

TY - JOUR

T1 - Cutaneous graft-versus-host disease on Tc-99m leukocyte scintigraphy

AU - Mittra, Erik

AU - McDougall, I. Ross

PY - 2009/12/1

Y1 - 2009/12/1

N2 - Leukocyte scintigraphy has previously been used to evaluate gastrointestinal graft-versus-host disease (GVHD). No reports have described their utility in cutaneous GVHD or the ability of leukocyte scintigraphy to evaluate treatment response at any site. This case shows significant radiolabeled leukocyte uptake in a man with extensive cutaneous GVHD, with subsequent near complete resolution after therapy. As such, leukocyte scintigraphy may provide an alternate way to assess the burden of GVHD and response to treatment.

AB - Leukocyte scintigraphy has previously been used to evaluate gastrointestinal graft-versus-host disease (GVHD). No reports have described their utility in cutaneous GVHD or the ability of leukocyte scintigraphy to evaluate treatment response at any site. This case shows significant radiolabeled leukocyte uptake in a man with extensive cutaneous GVHD, with subsequent near complete resolution after therapy. As such, leukocyte scintigraphy may provide an alternate way to assess the burden of GVHD and response to treatment.

KW - Cutaneous

KW - Graft-versus-host disease

KW - Tc-99m leukocyte scan

KW - Treatment response

KW - WBC

UR - http://www.scopus.com/inward/record.url?scp=74249116888&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=74249116888&partnerID=8YFLogxK

U2 - 10.1097/RLU.0b013e3181bed148

DO - 10.1097/RLU.0b013e3181bed148

M3 - Article

VL - 34

SP - 894

EP - 895

JO - Clinical Nuclear Medicine

JF - Clinical Nuclear Medicine

SN - 0363-9762

IS - 12

ER -